Page last updated: 2024-09-03

celastrol and Leukemia, Myeloid, Acute

celastrol has been researched along with Leukemia, Myeloid, Acute in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coulibaly, A; Haas, A; Jakobs, A; Klempnauer, KH; Schmidt, TJ; Steinmann, S1
Berdel, WE; Coulibaly, A; Dassé, E; Frampton, J; Jakobs, A; Jose, J; Klempnauer, KH; Müller-Tidow, C; Schlenke, P; Schmidt, TJ; Schomburg, C; Steinmann, S; Trentmann, A; Uttarkar, S1
Ruan, X; Yu, X; Zhang, J; Zhao, Q1
Abboud, R; Carroll, M; Corbett, C; Guzman, ML; Hassane, DC; Jordan, CT; Li, X; Liesveld, JL; Young, F1

Other Studies

4 other study(ies) available for celastrol and Leukemia, Myeloid, Acute

ArticleYear
The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
    PloS one, 2018, Volume: 13, Issue:2

    Topics: 3T3-L1 Cells; Amino Acid Sequence; Animals; Antineoplastic Agents, Phytogenic; CCAAT-Enhancer-Binding Proteins; Cell Line; Cell Proliferation; Chickens; Cysteine; Gene Expression; Humans; Leukemia, Myeloid, Acute; Mice; Myeloid Cells; p300-CBP Transcription Factors; Pentacyclic Triterpenes; Protein Interaction Domains and Motifs; Proto-Oncogene Proteins c-myb; Quail; Triterpenes

2018
Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction.
    Blood, 2016, Mar-03, Volume: 127, Issue:9

    Topics: Animals; Cell Differentiation; Cell Proliferation; Chickens; Disease Models, Animal; E1A-Associated p300 Protein; Gene Expression Regulation, Leukemic; Hematopoietic Stem Cells; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Mice, Inbred C57BL; Molecular Targeted Therapy; Myeloid Cells; Pentacyclic Triterpenes; Protein Binding; Protein Structure, Tertiary; Proto-Oncogene Proteins c-myb; Small Molecule Libraries; Triterpenes

2016
Celastrol Induces Cell Apoptosis and Inhibits the Expression of the AML1-ETO/C-KIT Oncoprotein in t(8;21) Leukemia.
    Molecules (Basel, Switzerland), 2016, Apr-30, Volume: 21, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Core Binding Factor Alpha 2 Subunit; Down-Regulation; Humans; Leukemia, Myeloid, Acute; Pentacyclic Triterpenes; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-kit; RUNX1 Translocation Partner 1 Protein; Transcription Factors; Translocation, Genetic; Triterpenes

2016
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.
    Blood, 2008, Jun-15, Volume: 111, Issue:12

    Topics: Aldehydes; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Death; Cysteine Proteinase Inhibitors; Databases, Genetic; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Humans; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Mice, SCID; Models, Genetic; Neoplastic Stem Cells; Oligonucleotide Array Sequence Analysis; Pentacyclic Triterpenes; Sesquiterpenes; Terpenes; Triterpenes; Xenograft Model Antitumor Assays

2008